Compare Gartner Inc (IT) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gartner Inc vs Stryker Corporation — how do they compare? Gartner Inc trades at $191.54 (market cap $12.34B), while Stryker Corporation trades at $277.69 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 8.6× Gartner Inc's market cap, and Stryker Corporation pays a 1.27% dividend while Gartner Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gartner Inc for 64 Days and Stryker Corporation for 21 Days on average.
| IT | SYK | |
|---|---|---|
Market Cap | $12.34B | $106.24B |
Volume | 919,809 | 2,982,001 |
Sector | Technology | Health |
52-Week High | $258.17 | $388.35 |
52-Week Low | $125.68 | $269.75 |
Typical Hold Time | 64 Days | 21 Days |
Enterprise Value | $14.08B | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gartner (IT) trades at $191.02, up 2.83% with a bullish technical signal. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Financials show strong profitability with a 69.63% gross margin and 113.58% ROE, though net income declined in 2025. Recent news highlights AI advisory demand and Gartner's industry leadership, driving positive sentiment.
Outlook remains supported by robust contract value and AI-driven consulting growth, but risks include a high P/B ratio of 160.06 and a shareholder investigation. Analyst consensus is mixed with a $174.63 price target below the current price, suggesting caution despite bullish technicals.
Stryker (SYK) trades at $277.52, up 0.77% today, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279. Fundamentally, the company reported strong profitability with a 14.43% net income margin in 2026 and beat EPS estimates in two of the last three quarters. However, recent news highlights potential legal and manufacturing issues that have pressured investor sentiment.
The outlook is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities lie in SYK's robust earnings growth and market leadership in medical technology, but risks include ongoing legal investigations and persistent manufacturing challenges that could impact future performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gartner Inc
Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.
Read more on IT →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
